Surgical treatment of hypertrophic cardiomyopathy

References

• Kirklin JW, Ellis FH Jr. Surgical relief of diffuse subvalvular aortic stenosis. Circulation 24, 739–742 (1961).
   PubMed Web of Science ®Google Scholar
• Goodwin JF, Hollman A, Cleland WP, Teare D. Obstructive cardiomyopathy simulating aortic stenosis. Br. Heart J. 22, 403–414 (1960).
   PubMedGoogle Scholar
• Morrow AG, Brockenbrough EC. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy. Ann. Surg. 154, 181–189 (1961).
   PubMed Web of Science ®Google Scholar
• Pollock SG. Images in clinical medicine. Pressure tracings in obstructive cardiomyopathy. N. Engl. J. Med. 331(4), 238 (1994).
   Google Scholar
• Schaff HV, Said SM. Transaortic extended septal myectomy for hypertrophic cardiomyopathy. Oper. Tech. Thorac. Cardiovas. Surg. (2012) (In Press).
   Google Scholar
• Chen MS, McCarthy PM, Lever HM, Smedira NG, Lytle BL. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy. Am. J. Cardiol. 93(3), 373–375 (2004).
   Google Scholar
• Cape EG, Simons D, Jimoh A, Weyman AE, Yoganathan AP, Levine RA. Chordal geometry determines the shape and extent of systolic anterior mitral motion: in vitro studies. J. Am. Coll. Cardiol. 13(6), 1438–1448 (1989).
   Google Scholar
• Klues HG, Roberts WC, Maron BJ. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 84(3), 1188–1197 (1991).
   PubMed Web of Science ®Google Scholar
• Yang HS, Lee KS, Chaliki HP et al. Anomalous insertion of the papillary muscle causing left ventricular outflow obstruction: visualization by real-time three-dimensional echocardiography. Eur. J. Echocardiogr. 9(6), 855–860 (2008).
   PubMed Web of Science ®Google Scholar
• Maron BJ, Nishimura RA, Danielson GK. Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. Circulation 98(23), 2505–2508 (1998).
   Google Scholar
• Reis RL, Bolton MR, King JF, Pugh DM, Dunn MI, Mason DT. Anterior–superior displacement of papillary muscles producing obstruction and mitral regurgitation in idiopathic hypertrophic subaortic stenosis – operative relief by posterior–superior realignment of papillary muscles following ventricular septal myectomy. Circulation 50(2 Suppl)., II181–II188 (1974).
   Google Scholar
• Wan CK, Dearani JA, Sundt TM 3rd, Ommen SR, Schaff HV. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation? Ann. Thorac. Surg. 88(3), 727–731; discussion 731–732 (2009).
   Google Scholar
• Jebara VA, Mihaileanu S, Acar C, Brizard C, Grare P, Latremouille C. Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique. Circulation 88, II30–II34 (1993).
   Google Scholar
• Nishimura RA, Holmes DR Jr. Clinical practice. Hypertrophic obstructive cardiomyopathy. N. Engl. J. Med. 350(13), 1320–1327 (2004).
   PubMed Web of Science ®Google Scholar
• Gersh BJ, Maron BJ, Bonow RO et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. American College of Cardiology Foundation/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. J. Thorac. Cardiovasc. Surg. 142(6), e153–e203 (2011).
   PubMed Web of Science ®Google Scholar
• Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH 3rd. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J. Am. Coll. Cardiol. 36(3), 852–855 (2000).
   PubMed Web of Science ®Google Scholar
• Ommen SR, Maron BJ, Olivotto I et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 46(3), 470–476 (2005).
   PubMed Web of Science ®Google Scholar
• Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 116(2), 196–206; discussion 206 (2007).
   PubMedGoogle Scholar
• Sorajja P, Valeti U, Nishimura RA et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 118(2), 131–139 (2008).
   Google Scholar
• Maron BJ. Commentary and re-appraisal: surgical septal myectomy vs. alcohol ablation: after a decade of controversy and mismatch between clinical practice and guidelines. Prog. Cardiovasc. Dis. 54(6), 523–528 (2012).
   Google Scholar
• Chang SM, Lakkis NM, Franklin J, Spencer WH III, Nagueh SF. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation 109(7), 824–827 (2004)
   PubMed Web of Science ®Google Scholar
• ElBardissi AW, Dearani JA, Nishimura RA, Ommen SR, Stulak JM, Schaff HV. Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy. Mayo Clin. Proc. 82(12), 1516–1522 (2007).
   PubMed Web of Science ®Google Scholar
• Schaff HV, Brown ML, Dearani JA et al. Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 139(3), 634–640 (2010).
   Google Scholar
• Maron BJ, Roberts WC, Edwards JE, McAllister HA Jr, Foley DD, Epstein SE. Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am. J. Cardiol. 41(5), 803–810 (1978).
   PubMed Web of Science ®Google Scholar
• McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am. J. Cardiol. 47(3), 532–538 (1981).
   PubMed Web of Science ®Google Scholar
• Altarabsheh SE, Dearani JA, Burkhart HM et al. Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults. Ann. Thorac. Surg. 95(2), 663–639; discussion 669 (2013).
   Google Scholar
• Schaff HV, Dearani JA, Ommen SR, Sorajja P, Nishimura RA. Expanding the indications for septalmyectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. J. Thorac. Cardiovasc. Surg. 143(2), 303–309 (2012).
   Google Scholar
• Williams WG, Rebeyka IM. Surgical intervention and support for cardiomyopathies of childhood. Prog. Pediatr. Cardiol. 1, 61–71 (1992).
   Google Scholar
• Minakata K, Dearani JA, Schaff HV, O’Leary PW, Ommen SR, Danielson GK. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann. Thorac. Surg. 80(3), 851–856 (2005).
   Google Scholar
• McCann GP, Van Dockum WG, Beek AM et al. Extent of myocardial infarction and reverse remodeling assessed by cardiac magnetic resonance in patients with and without right bundle branch block following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am. J. Cardiol. 99(4), 563–567 (2007).
   PubMed Web of Science ®Google Scholar
• McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 94(3), 467–471 (1996).
   Web of Science ®Google Scholar
• Said SM, Schaff HV, Abel MD, Dearani JA. Transapical approach for apical myectomy and relief of midventricular obstruction in hypertrophic cardiomyopathy. J. Card. Surg. 27(4), 443–448 (2012).
   Google Scholar